Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin and Nicotine Interaction on Attention
NCT03416569Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Mar 2018
- Primary completion
- Jan 2019
- Modality
- Transdermal Patches, Small Molecules
01
Overview
Randomised, double-blind trial of nicotine patch in Alzheimer's disease (AD), schizophrenia and attention deficit hyperactivity disorder (ADHD), sponsored by University of Maryland, Baltimore. Primary endpoints: Spatial Attentional Resource Allocation Task reaction time, Spatial Attentional Resource Allocation Task omission errors and 4 more. Planned start Mar 2018; status: withdrawn.
02
Drugs
nicotine patch
03
Conditions
Alzheimer's disease (AD)schizophreniaattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03416569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416569.